Consistently, most studies, including a meta-analysis on NSCLC, renal cell carcinoma, ovarian cancer, gastric cancer, and a few other cancers, showed that expression of LAG3 on TILs is associated with better survival [40]. This evidence concerns the gene LAG3 and non-small cell lung carcinoma.